结核病诊断和管理的发展
Jason A Tye-Din1,2,3,4
1Immunology Division Walter and Eliza Hall Institute Parkville Victoria Australia.
概括
对腹腔疾病的看法正在从以肠道为重点转变为全身T细胞反应. 新的生物标志物可能能够实现准确的免疫诊断,可能避免患者面临质挑战.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 遗传学 遗传学 是一个
背景情况:
- 结肠病的理解正在发展,超越了以肠为中心的模型.
- 免疫和遗传因素突出显示,在病变发生过程中,T细胞对质产生系统性反应.
- 越来越多地认识到用于诊断的小肠组织学的局限性.
研究的目的:
- 审查不断发展的对乳病病原体的理解.
- 讨论诊断方法的进展,包括血清学方法和新生物标志物.
- 探索诊断,治疗和开发新的治疗方法的挑战.
主要方法:
- 对目前关于乳疾病免疫学,遗传学和诊断的文献的综述.
- 对新的生物标志物的分析,如用于质特异性T细胞识别的互白素-2.
- 评估诊断,治疗疗效和临床试验设计方面的挑战.
主要成果:
- 免疫和遗传洞察力强调系统性T细胞对质的反应.
- 血清学诊断在成年人中越来越准确,反映了儿童的发现.
- 新型生物标志物显示出高灵敏度和特异性,可能消除对质挑战的需求.
- 无症状的疾病和肠外表现使诊断复杂化.
- 无质饮食仍然具有限制性,关于安全质摄入门的数据有限.
- 持续的症状和肠病是常见的,需要系统的评估.
- 缓慢反应性疾病和质过敏是新兴的概念.
- 目前还没有注册用于心脏病的特定药物,正在进行治疗和临床试验设计的研究.
结论:
- 结肠病越来越多地被视为一种系统性T细胞介导疾病.
- 生物标志物和血清检测方面的进展为非侵入性诊断提供了潜在的潜力.
- 在管理疾病方面仍然存在重大挑战,包括治疗坚持和开发有效疗法.
- 新型免疫工具对于推进临床试验设计和评估治疗疗效至关重要.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
01:29Chronic Pancreatitis II: Collaborative Care
84
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
84
01:30Serum Laboratory Studies, Stool Test, Breath Test
331
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
331
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
109
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
109
01:29Inflammatory Bowel Disease IV: Pharmacological Management
125
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
125
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
160
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
160